Albumin News and Research

RSS
Launch date announced for Abraxane to treat metastatic breast cancer

Launch date announced for Abraxane to treat metastatic breast cancer

Abraxane, first in a new class of albumin-bound nanotechnology for the treatment of metastatic breast cancer

Abraxane, first in a new class of albumin-bound nanotechnology for the treatment of metastatic breast cancer

FDA approves Abraxane for metastatic breast cancer

FDA approves Abraxane for metastatic breast cancer

Transplanted bone marrow cells reduce liver fibrosis in mice

Transplanted bone marrow cells reduce liver fibrosis in mice

Israeli developed fruit called pomelit, lowers blood cholesterol

Israeli developed fruit called pomelit, lowers blood cholesterol

Sit down rounds improve outcomes for kidney dialysis patients

Sit down rounds improve outcomes for kidney dialysis patients

Human Genome Sciences announces agreement with GSK for development of drug to treat diabetes

Human Genome Sciences announces agreement with GSK for development of drug to treat diabetes

Wyeth gets approval for needle-less syringe for the treatment of hemophilia

Wyeth gets approval for needle-less syringe for the treatment of hemophilia

Correlation between HCV viral load and severity of liver disease

Correlation between HCV viral load and severity of liver disease

Isolated soy protein shown to benefit type 2 diabetics

Isolated soy protein shown to benefit type 2 diabetics

Major campaign victory will create safer environments for children with food allergies

Major campaign victory will create safer environments for children with food allergies

World's largest study into intensive care

World's largest study into intensive care

Investigational drug Abraxane is active and well tolerated in women with metastatic breast cancer

Investigational drug Abraxane is active and well tolerated in women with metastatic breast cancer

Bone marrow stem cells exposed to damaged liver tissue quickly convert into healthy liver cells

Bone marrow stem cells exposed to damaged liver tissue quickly convert into healthy liver cells

Human Genome Sciences has begun dosing patients with chronic hep C drug

Human Genome Sciences has begun dosing patients with chronic hep C drug

Causes of hepatitis and potential therapies that may improve care presented in study

Causes of hepatitis and potential therapies that may improve care presented in study

Sainsbury's potato chips cause allergic reactions

Sainsbury's potato chips cause allergic reactions

New device filters blood supplies on-site reducing the possible transmission of Creutzfeldt-Jakob disease

New device filters blood supplies on-site reducing the possible transmission of Creutzfeldt-Jakob disease